๐Ÿ””Stock Alerts via Telegram โ€” Free for All Users

INMD Stock Risk & Deep Value Analysis

Inmode Ltd

DVR Score

8.7

out of 10

Hidden Gem

The Bottom Line on INMD

We analyzed Inmode Ltd using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran INMD through our deep value framework โ€” analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Mar 16, 2026โ€ขRun Fresh Analysis โ†’

๐Ÿ“ˆINMD Performance Overview3yr weekly

๐Ÿ“Š

Unlock INMD Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close ยท Quarterly revenue & EPS ยท DVR score history

INMD Stock Risk Analysis

Overall Risk

Moderate

Financial Risk

Low

Market Risk

Medium

INMD Deep Value Analysis

InMode retains significant 10x potential within 3-5 years, underpinned by its market leadership in minimally invasive aesthetic devices. The company's proprietary RF technology (e.g., Morpheus8) continues to drive brand recognition and a sticky business model with recurring consumable revenue. Financial health remains exceptionally strong (debt-free, cash-rich, consistently profitable). While macro headwinds have slowed growth over the past year, the core strategic vision for market expansion and innovation is intact. Leadership is proven, and a low current valuation, combined with strong fundamentals and ongoing product development, creates a compelling risk-reward profile for substantial re-rating as market conditions normalize and growth re-accelerates. No significant red flags indicate a 'dud'.

Compare INMD to Similar Stocks

See how Inmode Ltd stacks up against related companies in our head-to-head analysis.

INMD Red Flags & Warning Signs

Premium
  • โš 

    Slower-than-expected recovery in consumer discretionary spending for aesthetics

  • โš 

    New, highly competitive technology emerging from rivals

  • โš 

    Negative regulatory changes impacting medical device sales or approvals

  • โš 

    Increased price pressure on devices or consumables

Unlock INMD Red Flags & Risk Warnings

Premium members see every risk event we found.

๐Ÿ“ˆ

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

๐Ÿ”ฅ New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

  • โœ“ Catalysts, bull case, moat & red flags
  • โœ“ Unlimited stock analyses + alerts
  • โœ“ Full database, search & portfolio (50 stocks)
Get Premium โ€” $47/yr

7-day money back ยท Cancel anytime

INMD Competitive Moat Analysis

Premium

Moat Rating

Narrow

Moat Trend

Stable

Moat Sources

3 Identified

Intangible Assets/IPBrand PowerSwitching Costs

InMode's moat is largely protected by its proprietary radiofrequency (RF) technology and a robust patent portfolio. The strong brand recognition of products like Morpheus8 creates significant customer loyalty and a network effect among clinicians. Switching costs arise from the training required to operate InMode platforms and the continued purchase of proprietary consumables. However, the medical aesthetics market is dynamic, requiring continuous innovation to maintain this edge.

INMD Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

INMD Catalysts & Growth Drivers

Near-Term (0-6 months)

  • โ€ขQ1 2026 Earnings (Estimated early-May 2026)
  • โ€ขLaunch of new handpieces or software upgrades for existing platforms
  • โ€ขPositive commentary on recovery of elective procedure demand

Medium-Term (6-18 months)

  • โ€ขExpansion into new international markets (e.g., Asia Pacific, Latin America)
  • โ€ขMajor regulatory approvals for new platforms or indications
  • โ€ขStrategic partnerships to expand clinic adoption or training programs

Long-Term (18+ months)

  • โ€ขFurther penetration into the broader medical aesthetics market, potentially through M&A
  • โ€ขDisruption of traditional surgical procedures with less invasive alternatives
  • โ€ขEstablishment of InMode as the dominant player in RF-based aesthetics

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

INMD Bull Case: What Could Go Right

  • โœ“

    Acceleration in year-over-year and sequential revenue growth rates

  • โœ“

    Positive commentary and strong guidance from management regarding market recovery

  • โœ“

    Continued high adoption rates of new product launches and handpieces

Bull Case Analysis

See what could go right with Premium

๐Ÿ””

Never miss a move on INMD

Create a free account to set price alerts and get notified on Telegram when INMD hits your targets.

๐Ÿ“Š Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

FAQ

What is the DVR Score for Inmode Ltd (INMD)?

As of March 16, 2026, Inmode Ltd has a DVR Score of 8.7 out of 10, placing it in the "Hidden Gem" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the risk level for INMD stock?

Our analysis rates Inmode Ltd's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

How often is the INMD DVR analysis updated?

Our AI-powered analysis of Inmode Ltd is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 16, 2026.

Important Disclaimer โ€“ Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.